Recent development of bifunctional small molecules to study metal-amyloid-β species in Alzheimer's disease
|dc.contributor.author||Joseph J. Braymer,||ko|
|dc.contributor.author||Lim, Mi Hee||ko|
|dc.identifier.citation||International Journal of Alzheimer's Disease, v.2011, no., pp.623051 -||ko|
|dc.description.abstract||Alzheimer's disease (AD) is a multifactorial neurodegenerative disease related to the deposition of aggregated amyloid-β (Aβ) peptides in the brain. It has been proposed that metal ion dyshomeostasis and miscompartmentalization contribute to AD progression, especially as metal ions (e.g., Cu(II) and Zn(II)) found in Aβ plaques of the diseased brain can bind to Aβ and be linked to aggregation and neurotoxicity. The role of metal ions in AD pathogenesis, however, is uncertain. To accelerate understanding in this area and contribute to therapeutic development, recent efforts to devise suitable chemical reagents that can target metal ions associated with Aβ have been made using rational structure-based design that combines two functions (metal chelation and Aβ interaction) in the same molecule. This paper presents bifunctional compounds developed by two different design strategies (linkage or incorporation) and discusses progress in their applications as chemical tools and/or potential therapeutics.||ko|
|dc.publisher||Hindawi Publishing Corporation||ko|
|dc.title||Recent development of bifunctional small molecules to study metal-amyloid-β species in Alzheimer's disease||ko|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.